UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer

Anti-cancer drugs, 2022-02, Vol.33 (2), p.142-148

2022

Volltextzugriff (PDF)

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Anti-cancer drugs, 2022-01, Vol.33 (1), p.e477-e485

2022

Volltextzugriff (PDF)

Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer

Anti-cancer drugs, 2020-03, Vol.31 (3), p.292-297

2020

Volltextzugriff (PDF)

Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study

Anti-cancer drugs, 2024-06, Vol.35 (5), p.412-417

2024

Volltextzugriff (PDF)

Study on the therapeutic effect of sintilimab combined with modified DCF regimen on advanced gastric cancer and its impact on Th1/Th2 immune balance

Anti-cancer drugs, 2024-09, Vol.35 (8), p.780-788

2024

Volltextzugriff (PDF)

Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients

Anti-cancer drugs, 2022-01, Vol.33 (1), p.e541-e547

2022

Volltextzugriff (PDF)

Alternative drug formulations of docetaxel: a review

Anti-cancer drugs, 2007-02, Vol.18 (2), p.95-103

2007

Volltextzugriff (PDF)

Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review

Anti-cancer drugs, 2018-06, Vol.29 (5), p.477-481

2018

Volltextzugriff (PDF)

Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cells

Anti-cancer drugs, 2019-04, Vol.30 (4), p.339-346

2019

Volltextzugriff (PDF)

Use of pertuzumab and trastuzumab during pregnancy

Anti-cancer drugs, 2018-09, Vol.29 (8), p.810-813

2018

Volltextzugriff (PDF)

Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review

Anti-cancer drugs, 2014-06, Vol.25 Update on Taxanes in Cancer Therapy (5), p.488-494

2014

Volltextzugriff (PDF)

Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition

Anti-cancer drugs, 2018-10, Vol.29 (9), p.871-879

2018

Volltextzugriff (PDF)

Time above threshold plasma concentrations as pharmacokinetic parameter in the comparison of oral and intravenous docetaxel treatment of breast cancer tumors

Anti-cancer drugs, 2023-02, Vol.34 (2), p.281-289

2023

Volltextzugriff (PDF)

Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching

Anti-cancer drugs, 2019-03, Vol.30 (3), p.295-301

2019

Volltextzugriff (PDF)

Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema

Anti-cancer drugs, 2017-03, Vol.28 (3), p.350-355

2017

Volltextzugriff (PDF)

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study

Anti-cancer drugs, 2020-03, Vol.31 (3), p.298-303

2020

Volltextzugriff (PDF)

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

Anti-cancer drugs, 2008-10, Vol.19 (9), p.899-909

2008

Volltextzugriff (PDF)

Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)

Anti-cancer drugs, 2020-06, Vol.31 (5), p.463-472

2020

Volltextzugriff (PDF)

Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?

Anti-cancer drugs, 2018-04, Vol.29 (4), p.287-294

2018

Volltextzugriff (PDF)

Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results

Anti-cancer drugs, 2017-01, Vol.28 (1), p.104-109

2017

Volltextzugriff (PDF)

Taxanes, past, present, and future impact on non-small cell lung cancer

Anti-cancer drugs, 2014-06, Vol.25 Update on Taxanes in Cancer Therapy (5), p.571-583

2014

Volltextzugriff (PDF)

Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells

Anti-cancer drugs, 2017-10, Vol.28 (9), p.989-1001

2017

Volltextzugriff (PDF)

Predictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post-docetaxel setting: a single-center cohort study

Anti-cancer drugs, 2020-08, Vol.31 (7), p.742-746

2020

Volltextzugriff (PDF)

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Anti-cancer drugs, 2018-09, Vol.29 (8), p.774-785

2018

Volltextzugriff (PDF)

Taxanes: their impact on gynecologic malignancy

Anti-cancer drugs, 2014-06, Vol.25 Update on Taxanes in Cancer Therapy (5), p.522-535

2014

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnti-Cancer Drugs

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(157)

Sprache

Englisch
(157)

Erscheinungsjahr

n.n

Thema

Docetaxel
(146)
Humans
(146)
Oncology
(144)
Life Sciences & Biomedicine
(143)
Pharmacology & Pharmacy
(143)
Science & Technology
(143)
Female
(94)
Middle Aged
(68)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(59)
Aged
(56)
Male
(56)
Taxoids
(56)
Paclitaxel - Analogs & Derivatives
(54)
Adult
(52)
Taxoids - Administration & Dosage
(48)
Breast Neoplasms - Drug Therapy
(46)
Antineoplastic Agents, Phytogenic - Therapeutic Use
(43)
Paclitaxel - Therapeutic Use
(34)
Paclitaxel - Administration & Dosage
(30)
Paclitaxel
(27)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Anticancer Drugs
(2)

Menü

Weitere Dienste

Einstellungen

Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer

Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study

Study on the therapeutic effect of sintilimab combined with modified DCF regimen on advanced gastric cancer and its impact on Th1/Th2 immune balance

Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients

Alternative drug formulations of docetaxel: a review

Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review

Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cells

Use of pertuzumab and trastuzumab during pregnancy

Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review

Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition

Time above threshold plasma concentrations as pharmacokinetic parameter in the comparison of oral and intravenous docetaxel treatment of breast cancer tumors

Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching

Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)

Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?

Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results

Taxanes, past, present, and future impact on non-small cell lung cancer

Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells

Predictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post-docetaxel setting: a single-center cohort study

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy

Taxanes: their impact on gynecologic malignancy

Aktive Filter

Suchergebnisse filtern